Francois Cedric (CIK 1658080) reported 32 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-14). Recent activity: Sell APLS (425,968 shares), Sell APLS (195,952 shares), Sell APLS (472,065 shares), Sell APLS (300,000 shares), Sell APLS (234,411 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 425,968 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 195,952 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 472,065 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 300,000 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 234,411 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Buy | 143,750 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 143,750 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 372,815 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 87,108 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Buy | 97,976 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 97,976 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Buy | 195,952 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 195,952 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 20,862 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 36,047 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 97,997 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Buy | 87,108 | $0 |
| 2026-03-13 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 64,869 | $0 |
| 2026-03-13 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Buy | 64,869 | $0 |
| 2026-02-05 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Buy | 8,840 | $33,238 |
| 2026-01-30 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Buy | 195,952 | $0 |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 27,192 | $591,970 |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 8,182 | $161,922 |
| 2026-01-15 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 10,186 | $226,027 |
| 2025-08-29 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer | Sell | 175,037 | $4.9M |
Source: SEC Form 4 filings · as of 2026-05-14